2002
DOI: 10.1358/dof.2002.027.11.857029
|View full text |Cite
|
Sign up to set email alerts
|

Progesterone receptor antagonists (antiprogestins)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 69 publications
0
2
0
Order By: Relevance
“…Many selective progesterone receptor modulators, characterized as full progesterone receptor antagonists or mixed agonist-antagonists have been designed [111][112][113][114][115][116][117][118][119][120][121][122][123][124]. The receptors also are targets for compounds that can modulate progesterone-dependent events.…”
Section: Progestin Antagonistsmentioning
confidence: 99%
“…Many selective progesterone receptor modulators, characterized as full progesterone receptor antagonists or mixed agonist-antagonists have been designed [111][112][113][114][115][116][117][118][119][120][121][122][123][124]. The receptors also are targets for compounds that can modulate progesterone-dependent events.…”
Section: Progestin Antagonistsmentioning
confidence: 99%
“…1 The PR antagonist mifepristone (RU-486) is prescribed for termination of pregnancy and also offers promise for the treatment of endometriosis, uterine fibroids, and breast cancer. 2 Recently, non-steroidal PR antagonists and partial agonists have been identified with improved reproductive tissue safety profiles. 3,4 Nevertheless, new chemotypes that are amenable to high-throughput synthesis are useful to further structural understanding of PR modulation.…”
mentioning
confidence: 99%